India must manufacture more APIs locally, depend less on China: Experts

India, the world’s third-largest drug producer by volumes, imports 70% of its APIs from China. For some APIs, especially antibiotics, dependence on China is over 90%. India’s top drug makers, including Dr Reddy’s, Lupin, Glenmark, Mylan, Zydus and Pfizer are dependent on China for APIs.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2ALqTEk
via IFTTT